Malignant olecranon bursitis in the setting of multiple myeloma relapse
Accepted for publication June 14, 2018
Correspondence
Maxwell M Krem, MD, PhD; maxwell.krem@louisville.edu
Disclosures The authors report no disclosures/conflicts of interest.
Citation JCSO 2018;16(4):e202-e205
©2018 Frontline Medical Communications
doi https://doi.org/10.12788/jcso.0393
Submit a paper here
Conclusion
Bursitis is a rare but thought-provoking potential manifestation of multiple myeloma and AL amyloidosis; we believe that our patient’s bursitis was related to plasma cell neoplasia based upon co-occurrence with disease relapse. His bursitis turned out to be an early indicator of impending systemic relapse. In this particular case, in which the patient wished to avoid surgical intervention, flow cytometry was of great value, and we believe that our case is the first report of malignant bursitis being diagnosed by flow cytometry. Our patient’s case shares similarities with other biopsy-confirmed cases of malignant bursitis, but we were able to avoid the need for surgical biopsy or bursal stripping.
The authors thank Jennifer Wilham MT (ASCP), Pat Byrd MT (ASCP), and Darlene Mann MT (ASCP) for their technical support.
,false
